Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 1883-1887, December 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kessel, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kessel, D.

Some Determinants of Camptothecin Responsiveness in Leukemia L1210 Cells1

David Kessel

Department of Pharmacology and Toxicology and Division of Oncology, University of Rochester School of Medicine, Rochester, New York 14620

The antineoplastic alkaloid camptothecin inhibits nucleic acid synthesis in leukemia L1210 cells; this inhibition is initially reversible, but becomes irreversible when exposure to the drug is prolonged. A drug-resistant subline, L1210/CN, can overcome camptothecin-induced inhibition of nucleic acid biosynthesis before this becomes irreversible. Unlike actinomycin D-resistant cell lines, L1210/CN was not characterized by a drug permeability barrier nor by altered levels of cell surface glycoprotein.

1 Supported by Grants CA-11198 and CA-11242 from NIH, a grant from the Monroe County Cancer and Leukemia Society, and institutional (General Research Support Grant) funds.

Received 5/ 3/71. Accepted 7/13/71.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. Ohdo, T. Makinosumi, T. Ishizaki, E. Yukawa, S. Higuchi, S. Nakano, and N. Ogawa
Cell Cycle-Dependent Chronotoxicity of Irinotecan Hydrochloride in Mice
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1383 - 1388.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.